Miss Rachel Hills
Teams and roles for Rachel Hills
Research Associate
Research Associate
Publication
2026
- Bratt-Leal, A. M. et al., 2026. Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease. Cell Stem Cell (10.1016/j.stem.2026.08.014)
- Barker, R. A. et al., 2026. The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.. Nature Biotechnology 44 , pp.70-78. (10.1038/s41587-025-02567-2)
2025
- Paisey, S. J. et al. 2025. Imaging of human stem cell-derived dopamine grafts correlates with behavioural recovery and reveals microstructural brain changes. Neurobiology of Disease 209 106910. (10.1016/j.nbd.2025.106910)
- Hakami, A. et al. 2025. Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death. Neurotherapeutics 22 (2) e00518. (10.1016/j.neurot.2024.e00518)
2023
- Hills, R. 2023. Characterisation and comparison of patient-derived cell therapy products in a pre-clinical Parkinson’s Disease model. MPhil Thesis , Cardiff University.
2022
- Lane, E. L. et al. 2022. Spontaneous graft-induced dyskinesias are independent of 5-HT neurons and levodopa priming in a model of Parkinson's disease. Movement Disorders 37 (3), pp.613-619. (10.1002/mds.28856)
2019
- Muha, V. et al., 2019. Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice. Open Biology 9 (11) 190192. (10.1098/rsob.190192)
2018
- McWilliams, T. et al., 2018. Phosphorylation of Parkin at Serine65 is essential for its activation in vivo. Open Biology 8 180108. (10.1098/rsob.180108)
Articles
- Bratt-Leal, A. M. et al., 2026. Genomic and transcriptomic quality control for an autologous iPSC-derived cell therapy for Parkinson’s disease. Cell Stem Cell (10.1016/j.stem.2026.08.014)
- Barker, R. A. et al., 2026. The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.. Nature Biotechnology 44 , pp.70-78. (10.1038/s41587-025-02567-2)
- Paisey, S. J. et al. 2025. Imaging of human stem cell-derived dopamine grafts correlates with behavioural recovery and reveals microstructural brain changes. Neurobiology of Disease 209 106910. (10.1016/j.nbd.2025.106910)
- Hakami, A. et al. 2025. Graft ischemia post cell transplantation to the brain: Glucose deprivation as the primary driver of rapid cell death. Neurotherapeutics 22 (2) e00518. (10.1016/j.neurot.2024.e00518)
- Lane, E. L. et al. 2022. Spontaneous graft-induced dyskinesias are independent of 5-HT neurons and levodopa priming in a model of Parkinson's disease. Movement Disorders 37 (3), pp.613-619. (10.1002/mds.28856)
- Muha, V. et al., 2019. Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice. Open Biology 9 (11) 190192. (10.1098/rsob.190192)
- McWilliams, T. et al., 2018. Phosphorylation of Parkin at Serine65 is essential for its activation in vivo. Open Biology 8 180108. (10.1098/rsob.180108)
Thesis
- Hills, R. 2023. Characterisation and comparison of patient-derived cell therapy products in a pre-clinical Parkinson’s Disease model. MPhil Thesis , Cardiff University.